The relationship between antipsychotic-induced hyperprolactinemia and menstrual disorders in women with schizophrenia; A systematic review;Relatie tussen antipsychoticageïnduceerde hyperprolactinemie en menstruatiestoornissen bij vrouwen met schizofrenie; Een systematische review

Tijdschrift voor Psychiatrie

Volumn 54, Issue 10, 2012, Pages 861-868

  Ouwehand, A Jelleke ^a   Mollema Schelwald, B M ^b   Knegtering, H ^c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b GGZ Groningen ^*  (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Antipsychotics; Hyperprolactinemia; Menstrual disorders; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; COCHRANE LIBRARY; HUMAN; HYPERPROLACTINEMIA; MEDLINE; MENSTRUATION DISORDER; PSYCINFO; SCHIZOPHRENIA; SYSTEMATIC REVIEW;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; HYPERPROLACTINEMIA; MENSTRUATION DISTURBANCES; MIDDLE AGED; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84867790730     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Beumont PJ, Gelder MG, Friesen GH, Harris GW, MacKinnon PC, Mandelbrote BM, e.a. The effects of phenothiazines on endocrine function: I. Patients with inappropriate lactation and amenorrhoea. Br J Psychiatry 1974; 124: 413-9.
2. Bobes J, Garc A-P, Rejas J, Hern NG, Garcia-Garcia M, Rico-Villademoros F, e.a. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study. J Sex Marital Ther 2003; 29: 125-47.
3. Brunelleschi S, Zeppegno P, Risso F, Cattaneo CI, Torre E. Risperidone-associated hyperprolactinemia: evaluation in twenty psychiatric outpatients. Pharmacol Res 2003; 48: 405-9. (Pubitemid 36945339)
4. Bushe C, Shaw M, Peveler RC. A review of the association between antipsychotic use and hyperprolactinaemia. J Psychopharmacol 2008; 22 (Suppl 2): 46-55.
5. Canuso CM, Goldstein JM, Wojcik J, Dawson R, Brandman D, Klibanski A, e.a. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Res 2002; 111: 11-20.
6. Coppen A. The prevalence of menstrual disorders in psychiatric patients. Br J Psychiatry 1965; 111: 155-67.
7. Crosignani PG. Current treatment issues in female hyperprolactinaemia. Eur J Obstet Gynaecol Reprod Biol 2006; 125: 152-64.
8. Dickson RA, Glazer WM. Neuroleptic-induced hyperprolactinemia. Schizophr Res 1999; 35 (Suppl): S75-S86. (Pubitemid 29133028)
9. Diczfalusy E, Lauritzen C. Oestrogene beim Menschen. Berlin: Springer; 1961.
10. Dossenbach M, Dyachkova Y, Pirildar S, Anders M, Khalil A, Araszkiewicz A, e.a. Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Eur Psychiatry 2006; 21: 251-8.
11. Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000; 80: 1523-631.
12. Ghadirian AM, Chouinard G, Annable L. Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. J Nerv Ment Dis 1982; 170: 463-7. (Pubitemid 12051650)
13. Haymann H. Menstruationssorrungen bei psychosen. Z Ges Neurol Psychiat 1913; 15: 511-5.
14. Heineman MJ, Bleker OP, Evers JLH, Heintz APM. Obstetrie en gynaecologie (6de druk). Maarssen: Elsevier Gezondheidszorg; 2007.
15. Jolly P. Menstruation und psychose. Arch Psychiatr Nervenkr 1915; 55: 637-9.
16. Kinon BJ, Gilmore JA, Liu H, Halbreich UM. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone. Psychoneuroendocrinology 2003; 28: 55-68. (Pubitemid 36332229)
17. Kinon BJ, Ahl J, Liu-Seifert H, Maguire GA. Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine. Psychoneuroendocrinology 2006; 31: 577-88.
18. Kleinberg DL, Davis JM, de Coster R, van Baelen B, Brecher M. Prolactin levels and adverse events in patients treated with risperidone. J Clin Psychopharmacol 1999; 19: 57-61. (Pubitemid 29047332)
19. Knegtering H, Ouwehand J, Sytema, S, Wiersma D. Menstrual disorders in schizophrenia, possible causes and consequences. Schizophr Bull 2009; 35 (Suppl 1): 64.
20. Linden van der MW, Westert GP, de Bakker DH, Schellevis FG. Tweede Nationale Studie naar ziekten en verrichtingen in de huisart-senpraktijk: klachten en aandoeningen in de huisarrsenpraktijk. Utrecht/Bilthoven: Nivel/RIVM; 2004.
21. Magharious W, Goff DC, Amico E. Relationship of gender and menstrual status to symptoms and medication side effects in patients with schizophrenia. Psychiatry Res 1998; 77: 159-66. (Pubitemid 28157267)
22. Malik P, Kemmler G, Hummer M, Riecher-Roessler A, Kahn RS, Fleischhacker WW, the EUFEST Study Group. Sexual dysfunction in first-episode schizophrenia patients. J Clin Psychopharmacol 2011; 31: 274-80.
23. Melkersson K. Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients. J Clin Psychiatry 2005; 66: 761-7. (Pubitemid 40942424)
24. Prentice DS, Deakin JWF. The role of neuroleptic drugs and organic mechanisms in the aetiology of menstrual irregularities in schizophrenic women. Schizophr Res 1992; 6: 114.
25. Riecher-Rossler A, Hafner H, Dutch-Strobel A, Stumbaum M. Gonadal function and its influence on psychopathology. A comparison of schizophrenic and non-schizophrenic female inpatients. Arch Womens Ment Health 1998; 1: 15-26. (Pubitemid 128484503)
26. Ripley HS, Papanicolaou GN. The menstrual cycle with vaginal smear studies in schizophrenia, depression and elation. Am J Psychiatry 1942; 98: 567-73.
27. Shroeter J. Die Menstruation in ihren Bezichungen zu den Psychosen. Allg Z Psychiat 1874; 30: 551-2.
28. Smith SM, O'Keane V, Murray R. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 2002a; 181: 49-55. (Pubitemid 34717838)
29. Smith S, Wheeler MJ, Murray R, O'Keane V. The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis. J Clin Psychopharmacol 2002b; 22: 109-14. (Pubitemid 34289384)
30. Wiegratz I, Kutschera E, Lee JH, Moore C, Mellinger U, Winkler UH, e.a. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins. Contraception 2003; 67: 25-32.
31. Yazigi RA, Quintero CH, Salameh WA. Prolactin disorders. Fertil Steril 1997; 67: 215-25. (Pubitemid 27052174)